Keloid or hypertrophic scar: The controversy: Review of the literature

Annals of Plastic Surgery

Volumn 54, Issue 6, 2005, Pages 676-680

  Atiyeh, Bishara S ^a   Costagliola, Michel ^b   Hayek, Shady N ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

Cutaneous scar; Dermal tumor; Hypertrophic scar; Keloid

Indexed keywords

CLINICAL EXAMINATION; DIFFERENTIAL DIAGNOSIS; HISTOPATHOLOGY; HUMAN; HYPERTROPHIC SCAR; KELOID; MEDICAL LITERATURE; MOLECULAR BIOLOGY; PLASTIC SURGERY; PRIORITY JOURNAL; REVIEW;

CICATRIX, HYPERTROPHIC; HUMANS; KELOID;

EID: 19444367049     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sap.0000164538.72375.93     Document Type: Review

References (38)

1. Tanaka A, Hatoko M, Tada H, et al. Expression of p53 family in scars. J Dermatol Science. 2004;34:17-24.
2. 2-terminal kinase/activator protein-1 activation. Mol Pharmacol. 2003;64:707-713.
3. Jimenez SA, Saitta B. Alteration of expression of the alpha 1(I) collagen gene (COL1A1) in systemic sclerosis (scleroderma). Springer Semin Immunopathol. 1999;21:397-414.
4. Uitto J, Kouba D. Cytokine modulation of extracellular matrix gene expression: relevance to fibrotic skin diseases. J Dermatol Sci. 2000;24: S60-S69.
5. Szulgit G, Rudolph R, Wandel A, et al. Alterations in fibroblast α1β1 integrin collagen receptor expression in keloids and hypertrophic scars. J Invest Dermatol. 2002;118:409-415.
6. Bayat AB, Bock O, Mrowietz U, et al. Genetic susceptibility to keloid disease and hypertrophic scarring: transforming growth factor beta 1 common polymorphisms and plasma levels. Plast Reconstr Surg. 2003;111:535-543.
7. Datubo-Brown DD. Keloids: a review of the literature. Br J Plast Surg. 1990;43:70-77.
8. Niessen FB, Spauwen PH, Schalkwijk J, et al. On the nature of hypertrophic scars and keloids: a review. Plast Reconstr Surg. 1999;104:1435-1458.
9. Amadeu TP, Braune AS, Porto LC, et al. Fibrillin-1 and elastin are differentially expressed in hypertrophic scars and keloids. Wound Repair Regen. 2004;12:169-174.
10. Sahl WJ, Clever H. Cutaneous scars: part 1. Int J Dermatol. 1994;33:681-691.
11. Sasaki A, Mueller RV, Xi G, et al. Intralesional cryotherapy for enhancing the involution of hypertrophic scars and keloids. Plast Reconstr Surg. 2003;111:1841-1852.
12. Russell SB, Trupin KM, Rodriguez-Eaton S, et al. Reduced growth-factor requirement of keloid-derived fibroblasts may account for tumor growth. Proc Natl Acad Sci USA. 1988;85:587-591.
13. Nirodi CS, Devalaraja R, Nanney LB, et al. Chemokine and chemokine receptor expression in keloid and normal fibroblasts. Wound Repair Regen. 2000;8:371-382.
14. Tuan TL, Nichter LS. The molecular basis of keloid and hypertrophic scar formation. Mol Med Today. 1998;4:19-24.
15. Rockwell WB, Cohen IK, Ehrlich HP. Keloids and hypertrophic scars: a comprehensive review. Plast Reconstr Surg. 1989;84:827-837.
16. Rekha A. Keloids: a frustrating hurdle in wound healing. Int Wound J. 2004;1:145-148.
17. De Felice B, Wilson RR, Nacca M, et al. Molecular characterization and expression of p63 isoforms in human keloids. Mol Gen Genomics. 2004;272:28-34.
18. Peacock EE Jr, Madden JW, Trier WC. Biological basis for the treatment of keloids and hypertrophic scars. South Med J. 1970;63:755-760.
19. English RS, Shenefelt PD. Keloids and hypertrophic scars. Dermatol Surg. 1999;25:631-638.
20. Mustoe TA, Cooler RD, Gold MH, et al, for the International Advisory Panel on Scar Management. International clinical recommendations on scar management. Plast Reconstr Surg. 2002;110:560-571.
21. Kischer CW. Comparative ultrastructure of hypertrophic scars and keloids. Scanning Microsc. 1984;pt 3:423-431.
22. Lu F, Gao JH, Li XJ. Immunohistochemical analysis of Fas protein expression in hypertrophic scar and keloid. Di Yi Jun Yi Da Xue Xue Bau. 2003;23:228-229, 232.
23. Ehrlich HP, Desmouliere A, Diegelmann RF, et al. Morphological and immunochemical differences between keloid and hypertrophic scar. Am J Pathol. 1994;145:105-113.
24. Bayat A, Bock O, Mrowietz U, et al. Genetic susceptibility to keloid disease and transforming growth factor beta 2 polymorphisms. Br J Plast Surg. 2002;55:283-286.
25. Lee JY, Yang CC, Chao SC, et al. Histopathological differential diagnosis of keloid and hypertrophic scar. Am J Dermatopathol. 2004;26:379-384.
26. Amadeu T, Braune A, Mandarim-de-Lacerda C, et al. Vascularization pattern in hypertrophic scars and keloids: a stereological analysis. Pathol Res Pract. 2003;199:469-473.
27. Cosman B, Crikelair GF, Ju DM, et al. The surgical treatment of keloids. Plast Reconstr Surg. 1961;27:335-345.
28. Blackburn WR, Cosman B. Histologic basis of keloid and hypertrophic scar differentiation. Arch Pathol. 1966;82:65-71.
29. Santucci M, Borgognoni L, Reali UM, et al. Keloids and hypertrophic scars of Caucasians show distinctive morphologic and immunophenotypic profiles. Virchows Arch. 2001;438:457-463.
30. Akasaka Y, Ishikawa Y, Ono I, et al. Enhanced expression of caspase-3 in hypertrophic scars and keloid: induction of caspase-3 and apoptosis in keloid fibroblasts in vitro. Lab Invest. 2000;80:345-357.
31. Teofoli P, Barduagni S, Ribuffo M, et al. Expression of Bcl-2, p53, c-jun and c-fos protooncogenes and hypertrophic scars. J Dermatol Sci. 1999;22:31-37.
32. Ladin DA, Hou Z, Patel D, et al. p53 And apoptosis alterations in keloids and keloid fibroblasts. Wound Repair Regen. 1998;6:28-37.
33. Ghassan MS, Ladin D, Plson J, et al. Analysis of p53 gene mutation in keloids using polymerase chain reaction-based single-strand conformation polymorphism and DNA sequencing. Arch Dermatol. 1998;134:963-967.
34. Chodon T, Sugihara T, Igawa HH, et al. Keloid-derived fibroblasts are refractory to Fas-mediated apoptosis and neutralization of autocrine transforming growth factor-beta1 can abrogate this resistance. Am J Pathol. 2000;157:1661-1669.
35. Younai S, Venters G, Vu S, et al. Role of growth factors in scar contraction: an in vitro analysis. Ann Plast Surg. 1996;36:495-501.
36. Swann DA, Garg HG, Jung W, et al. Studies on human scar tissue proteoglycans. J Invest Dermatol. 1985;84:527-531.
37. Jiang DY, Fu XB, Chen W, et al. Relationship of overexpression of angiogenesis factors and their receptors with invasive growth of keloid. Zhonghua Zheng Xing Wai Ke Za Zhi. 2004;20:128-131.
38. Lim IJ, Phan TT, Song C, et al. Investigation of the influence of keloid-derived keratinocytes on fibroblast growth and proliferation in vitro. Plast Reconstr Surg. 2001;107:797-808.